Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

GEN News Highlights offer you up-to-date and timely coverage of breaking news, including scientific breakthroughs, company acquisitions, significant collaborations, major drug approvals, facility openings and closings, FDA and other regulatory decisions, and layoffs during periods of biopharma restructuring.

  • Page 1 of 50 (1000 items) 1 2 3 4 5  ...  Last
  • Page 1 of 50 (1000 items) 1 2 3 4 5  ...  Last

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »